AA
IART icon

Ancora Advisors’s Integra LifeSciences IART Stock Holding History

Ancora Advisors’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.32K Sell
246
-355
-59% -$3.9K ﹤0.01% 2113
2025
Q4 		$7.46K Buy
+601
New +$7.99K ﹤0.01% 1866

Other funds holding IART

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Ancora Advisors's IART Position: Q1 2026 in Review

Ancora Advisors reduced its Integra LifeSciences (IART) stake by 59% in Q1 2026, selling an estimated $3.9K and leaving 246 shares worth $2.32K. The position accounts for ﹤0.01% of the portfolio, ranked #2113.

Ancora Advisors first reported a position in IART in Q4 2025 and has held it in 2 quarters since. The position peaked at $7.46K in Q4 2025. 201 funds tracked by Wall St. Rank hold IART as of Q1 2026.

  • Ancora Advisors held 246 shares of Integra LifeSciences worth $2.32K as of Q1 2026.
  • Ancora Advisors sold 355 Integra LifeSciences shares in Q1 2026, an estimated $3.9K.
  • Integra LifeSciences made up ﹤0.01% of Ancora Advisors's portfolio in Q1 2026, its #2113 holding.
  • Ancora Advisors first reported a position in Integra LifeSciences in Q4 2025 and has held it in 2 quarters since.
  • Ancora Advisors's Integra LifeSciences position peaked at $7.46K in Q4 2025.
  • 201 funds tracked by Wall St. Rank held Integra LifeSciences as of Q1 2026.

Based on Ancora Advisors's 13F filing for Q1 2026, filed 15 May 2026.